Cutler Group LP Theravance Biopharma, Inc. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	BUY	$7.42 - $11.05 $63,982 - $95,284	8,623 New	8,623 $95,000
Q2 2021 Jul 19, 2021	SELL	$14.52 - $22.46 $21,780 - $33,690	-1,500 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$16.57 - $21.08 $24,855 - $31,619	1,500 New	1,500 $30,000
Q2 2020 Jul 22, 2020	SELL	$20.64 - $30.69 $20,640 - $30,690	-1,000 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$17.84 - $31.21 $17,840 - $31,210	1,000 New	1,000 $23,000
Q4 2019 Feb 06, 2020	SELL	$16.12 - $25.89 $6,270 - $10,071	-389 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$16.51 - $23.78 $284,913 - $410,371	-17,257 Reduced 97.8%	389 $7,000
Q2 2019 Aug 09, 2019	BUY	$15.6 - $25.15 $142,677 - $230,021	9,146 Added 107.6%	17,646 $288,000
Q1 2019 May 10, 2019	BUY	$22.57 - $28.15 $191,845 - $239,275	8,500 New	8,500 $192,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $636M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.